Astellas Pharma Inc
TSE:4503
Astellas Pharma Inc
TSE:4503
Price:
1 558 JPY
2.16%
Market Closed
Updated:
May 3, 2024
Astellas Pharma Inc
Cash from Financing Activities
|
Astellas Pharma Inc
Cash from Financing Activities Peer Comparison
Comparables:
4502
4568
4578
4523
4519
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Astellas Pharma Inc
TSE:4503
|
Cash from Financing Activities
¥478.6B
|
CAGR 3-Years
53%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Cash from Financing Activities
-¥302.8B
|
CAGR 3-Years
29%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Cash from Financing Activities
-¥123.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Cash from Financing Activities
-¥60.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
8%
|
CAGR 10-Years
2%
|
|
|
Eisai Co Ltd
TSE:4523
|
Cash from Financing Activities
-¥39.8B
|
CAGR 3-Years
21%
|
CAGR 5-Years
22%
|
CAGR 10-Years
10%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Cash from Financing Activities
-¥139.3B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-20%
|
See Also
What is Astellas Pharma Inc's Cash from Financing Activities?
Cash from Financing Activities
478.6B
JPY
478.6B
JPY
Based on the financial report for Dec 31, 2023, Astellas Pharma Inc's Cash from Financing Activities amounts to 478.6B JPY.
What is Astellas Pharma Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
53%
53%
The average annual Cash from Financing Activities growth rates for Astellas Pharma Inc have been 53% over the past three years .
You don't have any saved screeners yet
